Ferritin levels in cancer vary enormously depending on the type and stage of disease, but readings several times the upper limit of normal are common, and in aggressive blood cancers the number can climb into the tens of thousands. In metastatic pancreatic cancer, for example, median ferritin has been reported around 830 ng/mL, well above the typical reference range of roughly 20 to 200 ng/mL for adult women and 20 to 500 ng/mL for adult men. What makes ferritin levels in cancer tricky to interpret is that the protein is not simply a marker of iron stores; it is deeply tangled with inflammation, tumor biology, and immune activity, so a high number rarely tells a straightforward story.
Why Ferritin Rises in Cancer
Ferritin is best known as the body’s main iron-storage protein, so the instinct when seeing a sky-high reading is to think there must be too much iron circulating. In most cancers, though, that is not the primary driver. Research on non-small-cell lung cancer found that the elevated ferritin seen in patients was better explained by inflammation and oxidative stress than by actual iron overload.1PubMed. Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer The same pattern shows up in blood cancers: a systematic review of acute myeloid leukemia noted that ferritin tracked closely with well-known inflammatory markers and likely reflected disease burden rather than excess iron in the body.2PubMed Central. Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis
Tumors also create a local environment that pushes ferritin production up. Immune cells called macrophages that infiltrate tumors secrete ferritin in response to inflammatory signals from the cancer itself. In breast tumors, macrophages in the surrounding tissue were the main source of ferritin secretion, and their output increased when exposed to pro-inflammatory molecules.3PubMed. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages So ferritin in a cancer patient’s blood often reflects two overlapping processes: the body’s general inflammatory response and the tumor’s own microenvironment cranking out the protein.
Typical Ranges by Cancer Type
There is no single “cancer ferritin level.” The numbers span a wide range depending on the tumor, its stage, and how much systemic inflammation is present. A few benchmarks from published studies give a sense of the landscape.
In hematologic cancers, ferritin tends to reach the highest values. Patients with Hodgkin’s disease, non-Hodgkin’s lymphoma, multiple myeloma, and several forms of leukemia have all been found to have significantly elevated serum ferritin.4PubMed. Serum ferritin levels in hematologic malignant neoplasms In critical-care settings, T/NK-cell lymphoma and acute myeloblastic leukemia were among the diagnoses most strongly associated with extremely high ferritin peaks.5PubMed Central. Differential Diagnosis of Hyperferritinemia in Critically Ill Patients Readings above 10,000 ng/mL are not unusual in aggressive blood cancers, and in the most extreme scenario, a related condition called hemophagocytic lymphohistiocytosis (HLH), which can be triggered by hematologic malignancies, ferritin has been documented at 387,000 μg/L and 138,000 μg/L.6PubMed Central. Falsely decreased ferritin concentrations in two patients with haemophagocytic lymphohistiocytosis: A case report
Solid tumors generally produce lower elevations, but the numbers still far exceed what a healthy person’s bloodwork would show. In a study of metastatic pancreatic cancer, the median ferritin was about 830 ng/mL, and patients whose ferritin fell below that median survived roughly 50% longer than those above it.7Journal of Clinical Oncology. Pretreatment serum ferritin and overall survival in metastatic pancreatic cancer In a separate pilot study of pancreatic cancer, patients who survived past 100 days had a median ferritin of about 240 μg/L, while those who did not had a median around 435 μg/L.8PubMed. Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study
For colorectal cancer that has relapsed or spread, a cutoff of 150 ng/mL separated patients into meaningfully different survival groups: those below it had a median survival of about 10 months, while those at or above it survived a median of roughly 4 months.9PubMed Central. Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer In breast cancer, ferritin showed a strong positive correlation with disease progression, meaning it climbed as the cancer advanced.10PubMed Central. Utility of ferritin and inflammatory biomarkers in the diagnosis of different stages of breast cancer
Ferritin and Liver Cancer
Liver cancer deserves its own discussion because the liver is the organ most involved in iron storage and ferritin production, which makes the relationship between ferritin levels and hepatocellular carcinoma (HCC) especially complicated. You might expect ferritin to be a reliable red flag for liver cancer, but the evidence is more nuanced than that.
In a large nested case-control study from China, the median ferritin in people who went on to develop primary liver cancer (about 110 μg/L) was not significantly different from the median in matched controls (about 100 μg/L), and there was no meaningful trend linking higher ferritin quartiles to liver cancer risk.11PubMed Central. Association between Serum Ferritin, Incident Primary Liver Cancer, and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case-Control Study That same study did find, however, that higher ferritin was associated with a 72% greater risk of dying from chronic liver disease overall.
Other research paints a somewhat different picture for patients already carrying hepatitis B. Among chronic HBV patients, those who eventually developed liver cancer had a baseline ferritin of about 188 ng/mL compared with 108 ng/mL in those who stayed cancer-free, and patients with ferritin above 200 ng/mL had roughly 2.4 times the risk of developing HCC.12PubMed Central. Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection An older Korean study of men with chronic HBV found that those whose ferritin stayed above 300 ng/mL had about a 50% chance of developing liver cancer over the follow-up period, compared with roughly 20% for men with lower levels.13PubMed. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma
The takeaway for liver cancer is that ferritin’s predictive power depends heavily on context. In people with chronic viral hepatitis and ongoing liver inflammation, persistently elevated ferritin signals higher risk. In a broader population, ferritin alone does not reliably distinguish who will develop liver cancer from who will not.
Does Ferritin Help Predict How Cancer Will Go?
Across many cancer types, higher ferritin at diagnosis tends to correlate with worse outcomes. The studies mentioned above in pancreatic and colorectal cancer illustrate this directly: patients with lower ferritin survived longer. In stage III pancreatic cancer treated with radiation, those with normal ferritin levels had a median survival of about 21 months compared with 11 months for those with elevated levels.14International Journal of Radiation Oncology, Biology, Physics. Prognostic Impact of Serum Ferritin Levels on Overall Survival in Patients With Stage III Pancreatic Cancer Treated With Hypofractionated Radiation Therapy In acute myeloid leukemia, elevated ferritin has been linked to reduced overall survival and disease-free survival.2PubMed Central. Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis
That said, ferritin is not used as a standalone diagnostic or prognostic marker the way something like PSA is used in prostate cancer. It is a nonspecific indicator: infections, autoimmune diseases, liver damage, and even vigorous exercise can all push ferritin up. Early work tracking ferritin alongside other tumor markers in lung cancer patients undergoing treatment found that serial measurements could help evaluate the effects of therapy, but that false negatives occurred often enough that ferritin should only be interpreted alongside other clinical and laboratory findings.15Cancer. Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy This principle still holds: ferritin is one piece of a larger puzzle, not a cancer test by itself.
What Ferritin Does Inside Tumors
Beyond being a marker you can measure in blood, ferritin plays active biological roles that may help tumors grow. One of the more striking findings is that ferritin can promote the formation of new blood vessels, a process tumors depend on for their oxygen and nutrient supply. In a prostate cancer model, ferritin opposed the effects of a natural antiangiogenic molecule and restored tumor-driven blood vessel growth, and this effect did not depend on the iron stored inside the ferritin protein.16PubMed Central. Regulatory effects of ferritin on angiogenesis
Ferritin also appears to protect cancer cells from a specific type of cell death called ferroptosis, which is triggered by a buildup of damaging lipid molecules. Cancer cells that ramp up their ferritin production become harder to kill through this pathway. In liver cancer cell lines, forced overexpression of the heavy chain of ferritin (FTH) sped up cell growth, enhanced migration, and made the cells specifically resistant to ferroptosis without affecting their sensitivity to conventional chemotherapy drugs.17PubMed Central. FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis Similar results appeared in breast and kidney cancer cells: when those cells detached from their surrounding tissue, mimicking how metastatic cells float through the body, they ramped up ferritin production, and knocking that ferritin down made them vulnerable to ferroptosis again.18iScience. Extracellular matrix detachment confers resistance to ferroptosis
This dual role, where ferritin acts as both a measurable blood marker and an active participant in tumor survival, helps explain why researchers are so interested in it. It is not just a bystander going up because cancer is present; it is part of the machinery that cancer cells exploit.
Can Lowering Iron Slow Cancer Down?
If tumors benefit from ferritin and iron, the logical question is whether stripping iron away can help fight them. Iron chelation therapy, which uses drugs that bind iron and pull it out of circulation, has been explored in this context. A systematic review of iron chelation in colorectal cancer found that most in vitro and animal studies showed chelators could inhibit the growth of colon cancer cells, though a few studies suggested the opposite effect under certain conditions.19PubMed Central. The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential In metastatic ovarian cancer, mice treated with the iron chelator deferiprone showed about a 25% increase in median survival, and combining it with the standard chemotherapy drug cisplatin roughly doubled the benefit.20Cancer Discovery. Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
On the radiation side, reducing ferritin inside tumor cells has shown promise for making cancer more sensitive to radiotherapy. In glioma (brain cancer) cells, knocking down the heavy chain of ferritin increased oxidative stress, and cells with low ferritin exposed to high-dose radiation accumulated more damage than cells with normal ferritin levels.21Journal of Cancer Biology & Treatment. Role of H-Ferritin in Radiosensitivity of Human Glioma Cells The logic is straightforward: ferritin soaks up the loose iron that would otherwise participate in generating the free radicals radiation relies on to kill cells. Remove the sponge, and radiation hits harder.
These findings are mostly preclinical, meaning they come from lab dishes and animal models. Iron chelation has not yet become a routine part of cancer treatment, and there are real concerns about depleting iron in patients who may already be anemic from their disease or chemotherapy. But the research direction is active and the early results are intriguing enough to keep pushing.
Ferritin as a Drug Delivery Vehicle
Here is a twist that catches most people off guard: the same protein that rises in cancer patients’ blood is being engineered as a tool to treat cancer. Ferritin naturally forms a hollow cage-like structure that can be loaded with drugs, and because cancer cells frequently overexpress a receptor (transferrin receptor 1, or TfR1) that ferritin binds to, the loaded protein can home in on tumors while largely sparing normal tissue.22PubMed Central. Design and application of ferritin-based nanomedicine for targeted cancer therapy
Proof-of-concept work has loaded the chemotherapy drug doxorubicin into ferritin nanocages. In animal models, these loaded nanocages bound to tumor cells through TfR1, were pulled inside the cell, and released the drug in the acidic interior of the cell’s lysosomes, delivering a lethal dose right where it was needed.23PubMed Central. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection Doxorubicin is effective but notorious for damaging the heart, so packaging it inside a protein shell that targets tumors could reduce side effects. Refining this approach has involved understanding how the surface charge of the ferritin cage affects its ability to enter cells through TfR1, since modifications to the protein can inadvertently block that receptor interaction.24PubMed. Overcoming Non-Specific Interactions for Efficient Encapsulation of Doxorubicin in Ferritin Nanocages for Targeted Drug Delivery
Ferritin-based nanomedicine is still in preclinical and early-phase territory, but the concept is appealing precisely because it exploits biology that cancer cells cannot easily give up. Tumors overexpress TfR1 because they need iron to fuel their rapid growth; the same receptor that feeds them iron can be used to deliver poison.
A Lab Pitfall That Can Hide Extreme Ferritin
One practical issue worth knowing about is a laboratory artifact called the “hook effect” that can produce dangerously misleading ferritin results. Standard immunoassays work by sandwiching the target molecule between two antibodies. When ferritin is astronomically high, it can overwhelm both antibodies, prevent the sandwich from forming, and cause the machine to report a falsely low or even falsely normal number. This is not a theoretical concern: in two patients with HLH whose actual ferritin levels were 387,000 and 138,000 μg/L, the initial lab results came back falsely low without any warning flag from the analyzer.6PubMed Central. Falsely decreased ferritin concentrations in two patients with haemophagocytic lymphohistiocytosis: A case report
The hook effect becomes especially relevant after treatments like CAR T-cell therapy, which can trigger massive immune activation and send ferritin soaring. If clinicians rely on the reported number without suspecting this artifact, they may underestimate how severe the inflammatory storm actually is.25PubMed Central. Diagnostic Pitfalls in Assessment of Ferritin Following CAR T-cell Therapy: Understanding the Hook Effect The fix is simple: when clinical signs suggest ferritin should be very high but the lab number looks oddly normal, the lab can dilute the sample and re-run it. Being aware the problem exists is most of the battle.
When Ferritin Is Not About Cancer
A high ferritin result on routine bloodwork understandably causes alarm, but cancer is only one of many reasons the number can be elevated. Liver inflammation from alcohol or fatty liver disease, chronic infections, autoimmune conditions like rheumatoid arthritis and lupus, and hereditary hemochromatosis (a genetic condition that causes iron overload) all push ferritin up. In critically ill patients, sepsis and acute liver failure were among the strongest independent predictors of peak ferritin, alongside hematologic malignancy.5PubMed Central. Differential Diagnosis of Hyperferritinemia in Critically Ill Patients Obesity and metabolic syndrome can produce modestly elevated readings as well, because excess fat tissue generates low-grade inflammation.
Context matters enormously. A ferritin of 500 ng/mL in someone with known hemochromatosis means something entirely different from the same number in someone with unexplained weight loss and night sweats. Physicians look at the full clinical picture, including other iron studies like transferrin saturation, inflammatory markers like C-reactive protein, liver enzymes, and the patient’s symptoms, before deciding what an elevated ferritin means. A single high reading, in isolation, is not grounds for suspecting cancer.
For people monitoring ferritin during cancer treatment, the number’s trajectory often matters more than any single value. A ferritin that drops during chemotherapy can signal the tumor is responding; one that climbs may suggest progression or a complicating infection. But as the early lung cancer studies cautioned, false negatives happen, and ferritin should always be read alongside other clinical data rather than treated as a reliable standalone signal.